Cite
HARVARD Citation
Revés, J. et al. (n.d.). P375 Faecal calprotectin variation after induction therapy with infliximab to predict clinical, endoscopic and ultrasonographic remission in Crohn's disease patients. Journal of Crohn's and colitis. p. i378. [Online].